April 17th 2025
The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.
April 15th 2025
Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.
April 9th 2025
AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.
As the US measles outbreak tops 600 cases, Texas reported a second child's death in a young girl who was unvaccinated and had no underlying health conditions.
Your daily dose of the clinical news you may have missed.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Seen in the ED Quiz: Epigastric Pain with Chills, Nausea
The patient denies fever, SOB, vomiting or diarrhea. He does admit discomfort around the right scapula. What is evident on the CT? What is your diagnosis?
High-dose Flu Vaccine Confers No Added Benefit for Patients with CVD
A high-dose influenza vaccine was no more effective than the standard-dose vaccine at reducing the risk of severe outcomes among patients with heart disease, NIH study finds.
CDC Reduces COVID-19 Quarantine Requirement
The CDC reduced the length of quarantine required for persons exposed to someone infected with SARS-CoV-2 from 14 days to 10 or to 7 with a negative test.
Baloxavir Marboxil Wins FDA Label Expansion for Post-exposure Flu Prevention
The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.
6 Essential COVID-19 Codes to Remember
COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.
Moderna COVID-19 Vaccine Candidate Achieves 94.5% Efficacy in Phase 3 Trial
Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.
COVID-19 is Not my First Epidemic
The author was a young medical student when the first signs of the HIV epidemic appeared and it shaped his career. How will COVID-19 impact today's young clinicians?
Influenza Coinfection with COVID-19: NIH Treatment Considerations
Recent NIH COVID-19 guideline updates include evidence-based considerations for treatment of patients hospitalized with flu and COVID-19 coinfection.
Hospitalized COVID-19 Patients Have More, More Severe Complications vs Patients with Influenza
The first study to compare COVID-19 and influenza complications in hospitalized patients found COVID-19 patients more likely to be admitted to ICU and to die.
NIH Updates Testing, Treatment Guidelines During Cocirculation of Influenza and COVID-19
The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.
FDA Issues EUA Guidance for COVID-19 Vaccines
The FDA has issued guidance for sponsors of requests for EUA for COVID-19 vaccines including details on clinical trial data required to support award of EUA.
The Presidential COVID-19 Treatment Regimen-to-date
From daily aspirin to RGN-CoV2 to zinc, the president of the United States has been treated for COVID-19 with a wide range of both authorized and unproven therapies.
Study: Antibiotic Prescription Durations for Common Infections Often Exceed Guidelines
Over half of antibiotic courses in a new study exceeded guideline-recommended minimum effective durations, translating to >54 million potentially excessive days.
Navigating the “Perfect Storm”: A COVID-19 Flu Season
The possibility of a flu season wrapped in a global pandemic may have health care professionals especially worried this year.
Genetic Mutations May Underlie Severe COVID-19 Illness
More than 10% of those who develop severe COVID-19 have misguided antibodies that derail the immune response, according to new research.
COVID-19 or the Flu? Preparing for the Overlap
Worried about the upcoming flu season overlapping with COVID-19? Get up to date on available tests and the clinical aspects of the diseases with our quick article.
COVID-19 Vaccine: Pharmaceutical Executives Pledge Safety Above All
CEOs of 9 drug companies involved in COVID-19 vaccine development signed a pledge ensuring that sound science and ethics will guide the process.
3 Influenza Season Imperatives: Vaccinate, Vaccinate, Vaccinate
The CDC estimates delivery of a record 194 to 198 million doses of influenza vaccine this year. The primary care imperative: vaccinate, vaccinate, vaccinate.
Phase 3 Trials Launched for AZ SARS-CoV2 Vaccine Candidate
The AstraZeneca-Oxford University investigational coronavirus disease 2019 (COVID-19) vaccine candidate, has expanded into a phase 3 clinical trial.
Upper Respiratory Disorders Symptom Checker: A 5-question Quiz
Some symptoms of COVID-19 overlap with the common cold, flu, and other respiratory diseases. See if you can differentiate between them in these 5 patient scenarios.
NIH COVID-19 Treatment Guidelines Updated Based on New Data
Treatment guidelines on COVID-19 from the NIH were updated today based on data from clinical trials of hydroxychloroquine, ivermectin, and IL-6 inhibitors.
Do Americans Trust Russia’s “Sputnik V” COVID-19 Vaccine?
Approximately 67% of US adults are wary about trusting Russia’s Sputnik V COVID-19 vaccine without proof, according to a new survey of >30 000 Americans.
Poll: Give COVID-19 Vaccine to High-risk Americans First
A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.
FDA Issues EUA for Convalescent Plasma as Potential COVID-19 Treatment
The FDA issued an emergency use authorization for convalescent plasma for the treatment of COVID-19 in hospitalized patients.
ID Expert Caught up in COVID-19: Switching Gears
VIDEO: NIH-funded infectious disease expert discusses convalescent plasma, remdesivir, corticosteroids, and the COVID-19 vaccine timeline.
Study: Flu Vaccination in Hospitalized High-risk Patients "Paradoxically" Underutilized
Groups at high risk for influenza and its complications were less likely to receive vaccination while hospitalized vs the general population, according to a new study.
5 Questions on CDC Guidance for Catch-up Vaccination during COVID-19
The COVID-19 pandemic makes timely catch-up vaccination against all vaccine-preventable diseases essential. Try these 5 questions on CDC recommendations.
Risk of Death from COVID-19 Among Obese Higher for Men, Younger Adults
Patients with severe obesity are 4-times as likely to die from COVID-19, a new study finds, with younger patients and men with obesity at highest risk.
Adult Pneumococcal Vaccine 2020: 5 Questions on ACIP Update
Pneumococcal vaccine should still be given to adults aged ≥65 years, but no longer to all adults in that population. Find out what you know - and what you may need to know.
ACIP Revises Adult Pneumococcal Vaccination Recommendations: Good, Bad, and Ugly
The ACIP, once more, revised its recommendations for administration of pneumococcal vaccination among adults aged ≥65 years. Is there a lesson learned here?